½ÃÀ庸°í¼­
»óǰÄÚµå
1446188

¼¼°èÀÇ ¼Ò ÇコÄÉ¾î ½ÃÀå(2024-2028³â)

Global Cattle Healthcare Market 2024-2028

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: TechNavio | ÆäÀÌÁö Á¤º¸: ¿µ¹® 169 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼Ò ÇコÄÉ¾î ½ÃÀåÀº 2023³âºÎÅÍ 2028³â¿¡ °ÉÃÄ 44¾ï 7,000¸¸ ´Þ·¯ È®´ëµÇ°í, ¿¹Ãø ±â°£ Áß ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)Àº 8.91%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼Ò ÇコÄÉ¾î ½ÃÀå¿¡ ´ëÇÑ ÀüüÀûÀÎ ºÐ¼®, ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ ´ë»óÀ¸·Î ÇÑ º¥´õ ºÐ¼® µîÀÇ Á¤º¸¸¦ °ÔÀçÇß½À´Ï´Ù.

ÇöÀçÀÇ ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ°ú ÃËÁø¿äÀÎ, ½ÃÀå ȯ°æ Àüü¿¡ °üÇÑ ÃֽŠºÐ¼®À» Á¦°øÇÕ´Ï´Ù. ¼Ò Áúº´ ºÎ´ã Áõ°¡, ¿¹¹æ ÇコÄÉ¾î ´ëÃ¥ÀÇ Á߿伺¿¡ ´ëÇÑ Ãà»ê ³ó°¡ÀÇ ÀÇ½Ä °í¾ç, ¼¼°èÀûÀÎ ¼Ò°í±â ¹× À¯Á¦Ç° ¼ö¿ä Áõ°¡ µîÀÌ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
±âÁسâ 2024
Á¾·á³â 2028
¿¹Ãø ±â°£ 2024-2028
¼ºÀå ¸ð¸àÅÒ °¡¼Ó
YOY 2024 7.53%
CAGR 8.91%
ÁõºÐ¾× 44¾ï 7,000¸¸ ´Þ·¯

º» Á¶»ç¿¡¼­´Â ÇâÈÄ ¸î ³â°£ ¼Ò ÇコÄÉ¾î ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿äÀÎ Áß Çϳª·Î¼­ Ãà»ê¾÷¿¡ÀÇ ½ÃÇÁÆ® Áõ°¡¸¦ µé°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¼öÀÇ·á¿Í ±â¼úÀÇ ¹ßÀü, ¼öÀÇ·á ¿ø°ÝÀÇ·á µ¿Çâ Áõ°¡´Â ½ÃÀåÀÇ Å« ¼ö¿ä·Î ¿¬°áµÉ °ÍÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå °³¿ä

Á¦2Àå ½ÃÀå ±¸µµ

  • ½ÃÀå »ýŰè

Á¦3Àå ½ÃÀå ±Ô¸ð

  • ½ÃÀåÀÇ Á¤ÀÇ
  • ½ÃÀå ºÎ¹® ºÐ¼®
  • ½ÃÀå ±Ô¸ð(2023³â)
  • ½ÃÀå Àü¸Á(2023-2028³â)

Á¦4Àå ½ÃÀå ±Ô¸ð ½ÇÀû

  • ¼¼°èÀÇ ¼¼°èÀÇ ¼Ò ÇコÄÉ¾î ½ÃÀå 2018-2022
  • À¯Çüº° ºÎ¹® ºÐ¼®(2018-2022³â)
  • Á¦Ç°º° ºÎ¹® ºÐ¼®(2018-2022³â)
  • Áö¿ªº° ºÎ¹® ºÐ¼®(2018-2022³â)
  • ±¹°¡º° ºÎ¹® ºÐ¼®(2018-2022³â)

Á¦5Àå Five Forces ºÐ¼®

  • Five Forces ¿ä¾à
  • ¹ÙÀ̾îÀÇ ±³¼··Â
  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù
  • °æÀï À§Çù
  • ½ÃÀå ÇöȲ

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­ : À¯Çüº°

  • ½ÃÀå ºÎ¹®
  • ºñ±³ : À¯Çüº°
  • ½Ä¿ë¿ì : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
  • Á¥¼Ò : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
  • ½ÃÀå ±âȸ : À¯Çüº°

Á¦7Àå ½ÃÀå ¼¼ºÐÈ­ : Á¦Ç°º°

  • ½ÃÀå ºÎ¹®
  • ºñ±³ : Á¦Ç°º°
  • ÀǾàǰ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
  • »ç·á÷°¡¹° : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
  • ¹é½Å : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
  • ±âŸ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
  • ½ÃÀå ±âȸ : Á¦Ç°º°

Á¦8Àå °í°´ »óȲ

  • °í°´ »óȲ °³¿ä

Á¦9Àå Áö¿ªº° »óȲ

  • Áö¿ªº° ¼¼ºÐÈ­
  • Áö¿ªº° ºñ±³
  • ºÏ¹Ì : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
  • À¯·´ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
  • ¾Æ½Ã¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
  • ¼¼°è ±âŸ Áö¿ª : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
  • ¹Ì±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
  • ÇÁ¶û½º : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
  • Àεµ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
  • µ¶ÀÏ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
  • Áß±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2023-2028³â)
  • ½ÃÀå ±âȸ : Áö¿ª »óȲº°

Á¦10Àå ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦ ¹× µ¿Çâ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
  • ¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
  • ½ÃÀå µ¿Çâ

Á¦11Àå º¥´õ ±¸µµ

  • °³¿ä
  • º¥´õ ±¸µµ
  • È¥¶õ »óȲ
  • ¾÷°è ¸®½ºÅ©

Á¦12Àå º¥´õ ºÐ¼®

  • ´ë»ó º¥´õ
  • º¥´õÀÇ ½ÃÀå Æ÷Áö¼Å´×
  • Biozyme Inc.
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Elanco Animal Health Inc.
  • IDEXX Laboratories Inc.
  • ImmuCell Corp.
  • Innovative Diagnostics
  • Kyoritsuseiyaku Corp.
  • Merck and Co. Inc.
  • Norbrook Laboratories Ltd.
  • Phibro Animal Health Corp.
  • Thermo Fisher Scientific Inc.
  • Vetoquinol SA
  • Virbac Group
  • Zoetis Inc.

Á¦13Àå ºÎ·Ï

LSH 24.03.15

The cattle healthcare market is forecasted to grow by USD 4.47 bn during 2023-2028, accelerating at a CAGR of 8.91% during the forecast period. The report on the cattle healthcare market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising burden of cattle diseases, growing awareness among cattle farmers on importance of preventive healthcare measures, and increasing demand for beef and dairy products worldwide.

Technavio's cattle healthcare market is segmented as below:

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20247.53%
CAGR8.91%
Incremental Value$4.47bn

By Type

  • Beef cattle
  • Dairy cattle

By Product

  • Pharmaceuticals
  • Feed additives
  • Vaccines
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the rising shift towards animal farming as one of the prime reasons driving the cattle healthcare market growth during the next few years. Also, advancements in veterinary medicine and technology and growing trend of telemedicine in veterinary care facilitates will lead to sizable demand in the market.

The report on the cattle healthcare market covers the following areas:

  • Cattle healthcare market sizing
  • Cattle healthcare market forecast
  • Cattle healthcare market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cattle healthcare market vendors that include Biozyme Inc., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Elanco Animal Health Inc., IDEXX Laboratories Inc., ImmuCell Corp., Indian Immunologicals Ltd., Innovative Diagnostics, International Health Care Ltd., Kyoritsuseiyaku Corp., Merck and Co. Inc., Norbrook Laboratories Ltd., Phibro Animal Health Corp., Thermo Fisher Scientific Inc., Vamso Biotec Pvt. Ltd., Vetoquinol SA, Virbac Group, Zenex Animal Health India Private Ltd., Zoetis Inc., and Zovix Pharmaceuticals. Also, the cattle healthcare market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview

2 Market Landscape

  • 2.1 Market ecosystem

3 Market Sizing

  • 3.1 Market definition
  • 3.2 Market segment analysis
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

  • 4.1 Global cattle healthcare market 2018 - 2022
  • 4.2 Type Segment Analysis 2018 - 2022
  • 4.3 Products Segment Analysis 2018 - 2022
  • 4.4 Geography Segment Analysis 2018 - 2022
  • 4.5 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis

  • 5.1 Five forces summary
  • 5.2 Bargaining power of buyers
  • 5.3 Bargaining power of suppliers
  • 5.4 Threat of new entrants
  • 5.5 Threat of substitutes
  • 5.6 Threat of rivalry
  • 5.7 Market condition

6 Market Segmentation by Type

  • 6.1 Market segments
  • 6.2 Comparison by Type
  • 6.3 Beef cattle - Market size and forecast 2023-2028
  • 6.4 Dairy cattle - Market size and forecast 2023-2028
  • 6.5 Market opportunity by Type

7 Market Segmentation by Product

  • 7.1 Market segments
  • 7.2 Comparison by Product
  • 7.3 Pharmaceuticals - Market size and forecast 2023-2028
  • 7.4 Feed additives - Market size and forecast 2023-2028
  • 7.5 Vaccines - Market size and forecast 2023-2028
  • 7.6 Others - Market size and forecast 2023-2028
  • 7.7 Market opportunity by Product

8 Customer Landscape

  • 8.1 Customer landscape overview

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • 9.2 Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
  • 9.4 Europe - Market size and forecast 2023-2028
  • 9.5 Asia - Market size and forecast 2023-2028
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • 9.7 US - Market size and forecast 2023-2028
  • 9.8 France - Market size and forecast 2023-2028
  • 9.9 India - Market size and forecast 2023-2028
  • 9.10 Germany - Market size and forecast 2023-2028
  • 9.11 China - Market size and forecast 2023-2028
  • 9.12 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • 11.3 Landscape disruption
  • 11.4 Industry risks

12 Vendor Analysis

  • 12.1 Vendors covered
  • 12.2 Market positioning of vendors
  • 12.3 Biozyme Inc.
  • 12.4 Boehringer Ingelheim International GmbH
  • 12.5 Ceva Sante Animale
  • 12.6 Elanco Animal Health Inc.
  • 12.7 IDEXX Laboratories Inc.
  • 12.8 ImmuCell Corp.
  • 12.9 Innovative Diagnostics
  • 12.10 Kyoritsuseiyaku Corp.
  • 12.11 Merck and Co. Inc.
  • 12.12 Norbrook Laboratories Ltd.
  • 12.13 Phibro Animal Health Corp.
  • 12.14 Thermo Fisher Scientific Inc.
  • 12.15 Vetoquinol SA
  • 12.16 Virbac Group
  • 12.17 Zoetis Inc.

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • 13.3 Currency conversion rates for US$
  • 13.4 Research methodology
  • 13.5 List of abbreviations
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦